Wednesday, April 26, 2017 |
4:00 PM - 5:00 PM CT
676 N. St. Clair Street, Suite 650, 6th Floor Conference Room A, Chicago, IL 60611 map it
Michael DiVito, PhD
Hepatocyte transplantation has been shown to partially correct metabolic deficiencies. This therapy could be used to temporarily improve metabolic function for patients waiting for a donor organ. Induced pluripotent stem cells (iPSCs), which can be differentiated into hepatocyte-like cells (iPSCHs), could be used for transplantation in place of primary hepatocytes. However, the main limitation of iPSCHs is a blunted phenotype with decreased functionality (P450 and synthetic function) compared to fresh human hepatocytes. The work presented discusses how various 3D co-culture configurations have been used to improve the maturation of iPSCHs.
Audience
- Faculty/Staff
- Student